| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-06 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
3e-06 |
| mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
3e-06 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
4e-06 |
| mRNA |
DMOG |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
5e-06 |
| mRNA |
GW-2580 |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
6e-06 |
| mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
| mRNA |
CAL-101 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
1e-05 |
| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
2e-05 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |